These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 36877026

  • 1. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis-oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance.
    Mishra NN, Abdelhady W, Elsayed AM, Lapitan C, Proctor RA, Rybak MJ, Miro JM, Bayer AS.
    Antimicrob Agents Chemother; 2023 Apr 18; 67(4):e0147222. PubMed ID: 36877026
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
    Garcia-de-la-Maria C, Xiong YQ, Pericas JM, Armero Y, Moreno A, Mishra NN, Rybak MJ, Tran TT, Arias CA, Sullam PM, Bayer AS, Miro JM.
    Antimicrob Agents Chemother; 2017 May 18; 61(5):. PubMed ID: 28264848
    [Abstract] [Full Text] [Related]

  • 4. Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies.
    Zapata B, Alvarez DN, Farah S, Garcia-de-la-Maria C, Miro JM, Sakoulas G, Bayer AS, Mishra NN.
    Curr Microbiol; 2018 Aug 18; 75(8):1062-1067. PubMed ID: 29651552
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Pericàs JM, Nathavitharana R, Garcia-de-la-Mària C, Falces C, Ambrosioni J, Almela M, García-González J, Quintana E, Marco F, Moreno A, Bayer AS, Miró JM, Karchmer AW, Hospital Clínic Endocarditis Study Group.
    Antimicrob Agents Chemother; 2019 Aug 18; 63(8):. PubMed ID: 31182540
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Strain-Specific Adaptations of Streptococcus mitis-oralis to Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics.
    Mishra NN, Tran TT, Arias CA, Seepersaud R, Sullam PM, Bayer AS.
    Antibiotics (Basel); 2020 Aug 15; 9(8):. PubMed ID: 32824132
    [Abstract] [Full Text] [Related]

  • 10. Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.
    Tran TT, Mishra NN, Seepersaud R, Diaz L, Rios R, Dinh AQ, Garcia-de-la-Maria C, Rybak MJ, Miro JM, Shelburne SA, Sullam PM, Bayer AS, Arias CA.
    Antimicrob Agents Chemother; 2019 Feb 15; 63(2):. PubMed ID: 30509945
    [Abstract] [Full Text] [Related]

  • 11. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect").
    Yang SJ, Xiong YQ, Boyle-Vavra S, Daum R, Jones T, Bayer AS.
    Antimicrob Agents Chemother; 2010 Aug 15; 54(8):3161-9. PubMed ID: 20547804
    [Abstract] [Full Text] [Related]

  • 12. Streptococcus mitis and S. oralis Lack a Requirement for CdsA, the Enzyme Required for Synthesis of Major Membrane Phospholipids in Bacteria.
    Adams HM, Joyce LR, Guan Z, Akins RL, Palmer KL.
    Antimicrob Agents Chemother; 2017 May 15; 61(5):. PubMed ID: 28223392
    [Abstract] [Full Text] [Related]

  • 13. Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus: In Vitro, Ex Vivo, and In Vivo Metrics.
    Mishra NN, Lew C, Abdelhady W, Lapitan CK, Proctor RA, Rose WE, Bayer AS.
    Antimicrob Agents Chemother; 2022 Jan 18; 66(1):e0164921. PubMed ID: 34694870
    [Abstract] [Full Text] [Related]

  • 14. Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in Streptococcus mitis-oralis.
    Yeaman MR, Chan LC, Mishra NN, Bayer AS.
    Antibiotics (Basel); 2021 Apr 08; 10(4):. PubMed ID: 33918000
    [Abstract] [Full Text] [Related]

  • 15. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ, Hady WA, Bayer AS, Chen L, Kreiswirth BN, Yang SJ.
    Antimicrob Agents Chemother; 2012 Nov 08; 56(11):5528-33. PubMed ID: 22890759
    [Abstract] [Full Text] [Related]

  • 16. Membrane Phenotypic, Metabolic and Genotypic Adaptations of Streptococcus oralis Strains Destined to Rapidly Develop Stable, High-Level Daptomycin Resistance during Daptomycin Exposures.
    Mishra NN, de Paula Baptista R, Tran TT, Lapitan CK, Garcia-de-la-Maria C, Miró JM, Proctor RA, Bayer AS.
    Antibiotics (Basel); 2023 Jun 21; 12(7):. PubMed ID: 37508179
    [Abstract] [Full Text] [Related]

  • 17. Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
    Kebriaei R, Stamper KC, Singh KV, Khan A, Rice SA, Dinh AQ, Tran TT, Murray BE, Arias CA, Rybak MJ.
    J Infect Dis; 2020 Oct 01; 222(9):1531-1539. PubMed ID: 32514561
    [Abstract] [Full Text] [Related]

  • 18. Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis.
    Parrett A, Reed JM, Gardner SG, Mishra NN, Bayer AS, Powers R, Somerville GA.
    BMC Microbiol; 2020 Jun 15; 20(1):162. PubMed ID: 32539684
    [Abstract] [Full Text] [Related]

  • 19. Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model.
    Kebriaei R, Bayer AS, Lapitan CK, Rybak MJ, Somerville GA, Mishra NN.
    Antibiotics (Basel); 2022 Oct 13; 11(10):. PubMed ID: 36290066
    [Abstract] [Full Text] [Related]

  • 20. Telavancin Is Active against Experimental Aortic Valve Endocarditis Caused by Daptomycin- and Methicillin-Resistant Staphylococcus aureus Strains.
    Abdelhady W, Bayer AS, Gonzales R, Li L, Xiong YQ.
    Antimicrob Agents Chemother; 2017 Feb 13; 61(2):. PubMed ID: 27872064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.